Amundi
RNAM

Amundi’s Avidity Biosciences RNAM Stock Holding History

Amundi’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,939
Closed -$284K – 2085
2025
Q4 		$284K Buy
+3,939
New +$254K ﹤0.01% 1667
2025
Q2 		– Sell
-52
Closed -$1.46K – 2074
2025
Q1 		$1.46K Buy
52
+32
+160% +$997 ﹤0.01% 1987
2024
Q4 		$599 Buy
+20
New +$836 ﹤0.01% 2092

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Amundi's RNAM Position: Q1 2026 in Review

Amundi sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 3,939 shares — an estimated $284K sold.

Amundi first reported a position in RNAM in Q4 2024 and held it in 3 quarters. The position peaked at $284K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Amundi reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Amundi sold 3,939 Avidity Biosciences shares in Q1 2026, an estimated $284K.
  • Amundi first reported a position in Avidity Biosciences in Q4 2024 and held it in 3 quarters.
  • Amundi's Avidity Biosciences position peaked at $284K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.